(01-08) 17:27 PST New York (AP) -- Looking to angle in an a market that is growing fast, Bristol-Myers will spend $2.5 billion to acquire hepatitis C drug developer Inhibitex Inc., which saw its share price double in...
San Francisco Chronicle: Business
Sun, 01/08/2012 - 6:27pm
(01-08) 17:27 PST New York (AP) -- Looking to angle in an a market that is growing fast, Bristol-Myers will spend $2.5 billion to acquire hepatitis C drug developer Inhibitex Inc., which saw its share price double in...